Sylvia Dyballa

Papers

Total Citations

H-Index

About

Sylvia Dyballa is a pioneering researcher at the intersection of developmental biology and cancer diagnostics, best known for her groundbreaking work in automating zebrafish xenograft models. Her primary research focuses on high-throughput microinjection technologies, precision oncology, and the development of in vivo platforms for personalized cancer therapy. Dyballa’s major contribution lies in engineering automated microinjection systems that overcome the labor-intensive, manual constraints of traditional zebrafish xenograft assays. By enabling precise, reproducible delivery of cancer cells into large numbers of fragile zebrafish larvae, her work transforms these models from niche research tools into scalable, clinically relevant diagnostic platforms. Her most-cited paper (2025, 5 citations) demonstrates the potential of this automation to predict patient-specific therapeutic responses, a breakthrough that could accelerate personalized treatment decisions. Dyballa’s research not only advances fundamental cancer biology but also bridges the gap between preclinical models and clinical practice, offering a cost-effective, high-throughput alternative to murine models. Her achievements highlight her as a leader in bioengineering and translational oncology, with her work poised to reshape how clinicians evaluate cancer therapeutics.